论文信息 - Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills. - 字舞流文

Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.

E. Ramos | J. Larrauri | J. Tovar | G. Prieto | M. Molina | J. Sarría | B. Pérez-Moneo

[1] G. Thiéfin,et al. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. , 2005, Joint, bone, spine : revue du rhumatisme.

[2] P. Prescott,et al. LETTER: Lack of Evidence for Fibrosing Colonopathy by 5-ASA in Humans , 2002, Digestive Diseases and Sciences.

[3] A. Angeli,et al. Adult fibrosing colonopathy associated with mesalazine treatment. , 2001 .

[4] P. Prescott,et al. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer , 1999, Pharmacoepidemiology and drug safety.

[5] Ginsberg Al,et al. Lack of evidence for fibrosing colonopathy by 5-ASA in humans. , 1999 .

[6] C. Powell. Colonic toxicity from pancreatins: a contemporary safety issue , 1999, The Lancet.

[7] B. Pawel,et al. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. , 1997, Human pathology.

[8] A. Smyth,et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes , 1994, The Lancet.